Cardiol Therapeutics Inc. Proceeds From Exercise Of Warrants
Cardiol Therapeutics Inc. (CRDL) reported Proceeds From Exercise Of Warrants of CAD 11.80 million for the 12-month period ending 2021-12-31, per its 40-F/A filed 2022-04-20.
Discontinued
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2022-04-20
| Period end | Proceeds From Exercise Of Warrants 12 month |
|---|---|
| 2021-12-31 | 11.80M CAD 40-F/A · filed 2022-04-20 |
| 2020-12-31 | 183.68K CAD 40-F/A · filed 2022-04-20 |